Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $8,820 - $9,816
-37 Reduced 2.09%
1,734 $457,000
Q1 2023

May 12, 2023

SELL
$229.71 - $259.35 $6,431 - $7,261
-28 Reduced 1.56%
1,771 $438,000
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $1,746 - $2,055
8 Added 0.45%
1,799 $457,000
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $102 - $528
-2 Reduced 0.11%
1,791 $399,000
Q2 2022

Aug 12, 2022

SELL
$234.74 - $275.42 $69,248 - $81,248
-295 Reduced 14.13%
1,793 $442,000
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $38,495 - $42,735
-158 Reduced 7.03%
2,088 $555,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $516,759 - $563,611
2,246 New
2,246 $565,000
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $2.05 Million - $2.26 Million
-8,828 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $2.05 Million - $2.25 Million
8,828 New
8,828 $2.15 Million
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $2.18 Million - $2.42 Million
-9,414 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $477,793 - $529,508
2,153 Added 29.65%
9,414 $2.36 Million
Q3 2020

Nov 16, 2020

SELL
$215.77 - $276.76 $1,941 - $2,490
-9 Reduced 0.12%
7,261 $1.69 Million
Q2 2020

Aug 19, 2020

SELL
$219.9 - $263.41 $381 Million - $456 Million
-1,732,246 Reduced 99.58%
7,270 $1.74 Million
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $381 Million - $456 Million
1,732,249 Added 23837.2%
1,739,516 $7,000
Q1 2020

May 15, 2020

BUY
$195.69 - $279.01 $7,436 - $10,602
38 Added 0.53%
7,267 $1.67 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $1.71 Million - $1.93 Million
7,229 New
7,229 $1.97 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Laidlaw Wealth Management LLC Portfolio

Follow Laidlaw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laidlaw Wealth Management LLC with notifications on news.